Interstitial lung diseases in a lung cancer screening trial

Sverzellati N., Guerci L., Randi G., Calabrò E., La Vecchia C., Marchianò A., Pesci A., Zompatori M., Pastorino U.

Source: Eur Respir J 2011; 38: 392-400
Journal Issue: August

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sverzellati N., Guerci L., Randi G., Calabrò E., La Vecchia C., Marchianò A., Pesci A., Zompatori M., Pastorino U.. Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2011; 38: 392-400

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes
Source: Eur Respir J 2010; 35: 146-151
Year: 2010



Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007



Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Screening for lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=71
Year: 2001

Prevalence and characterization of interstitial lung disease in a lung cancer screening program
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012



Smoking-induced lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=134
Year: 2007

The impact of a lung cancer computed tomography screening result on smoking abstinence
Source: Eur Respir J 2011; 37: 1466-1473
Year: 2011



Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Prevalence of interstitial lung disease (ILD) in a lung cancer screening program using low-dose computer tomography (CT)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011



Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001



Lung cancer and interstitial lung disease
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018


Early detection of COPD is important for lung cancer surveillance
Source: Eur Respir J 2012; 39: 1230-1240
Year: 2012



Prevalence of bronchiectasis in a lung cancer screnning program
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019


Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



The Asian experience in co-existing lung cancer and interstitial lung disease
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018


The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018

Prior lung disease and risk of lung cancer in women
Source: Eur Respir J 2005; 26: Suppl. 49, 598s
Year: 2005

Smoking-related interstitial lung disease
Source: Eur Respir Mon 2011; 54: 282-300
Year: 2011


Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation
Source: Eur Respir J 2007; 29: 453-461
Year: 2007